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Summary. Background and Objective. To date, the epidemiological studies of noncommunica-
ble diseases in Latvia were more episodic and covered only selected areas. The first national cross-
sectional population-based survey of cardiovascular risk factors after regaining independence was 
carried out to provide reliable information on the cardiovascular risk factor profile in adults.
Material and Methods. Computerized random sampling from the Registry of Latvian popula-
tion was carried out. A total of 6000 enrolled subjects aged 25–74 years were divided into 10 age 
subgroups. The data of 3807 respondents (63.5% of all) were included into the final analysis. 
Results. The mean number of cardiovascular risk factors was 2.99±0.026 per subject: 3.45±0.043 
and 2.72±0.030 for men and women, respectively. Of all the respondents, 75.2% had an increased 
total cholesterol level. Hypercholesterolemia was found in almost 56% of men and 41% of women in 
the age group of 25–34 years. Hyperglycemia was documented in 34.1% of the respondents (41.6% 
of men and 29.8% of women). More than two-thirds (67.8%) of the persons were overweight, while 
obesity was found in 25.6% of men and 32.6% of women. Arterial hypertension was identified in 
44.8% of the respondents; its prevalence was higher in men than women (52.9% vs. 40.2%). There 
were more current smokers among men than women (30.5% vs. 11.4%).
Conclusions. The levels of cardiovascular risk factors in Latvia were found to be relatively high. 
The data can be utilized as baseline characteristics that can be compared down the road including 
the monitoring of health prevention activities. 
Introduction 
An increasing prevalence of noncommunicable 
diseases is a major public health concern in many 
countries as well as in Latvia. The health profile of 
the population reflects many of the trends of East 
Europe, including high morbidity and mortality due 
to cardiovascular diseases. During the last 20 years, 
according to Latvian mortality statistics, cardiovas-
cular diseases accounted for 52%–54% of all deaths, 
and mortality rate remained to be high: 713.0 and 
792.7 per 100 000 population in 2000 to 2010, re-
spectively (1).
Limited information can be obtained from the 
morbidity data of the routine outpatient health sta-
tistics reports and public health databases for the 
assessment of disease prevalence. This is due to in-
sufficient information about the causes of diseases 
and contributing risk factors as well as the associa-
tion between these factors in the general popula-
tion. With respect to this information, epidemio-
logical studies present the opportunity to estimate 
the prevalence of risk factors and thus assist in plan-
ning resources and improving prevention strategies. 
Thus, registries and epidemiological studies should 
be considered as two sides of the same coin: one 
deals with collecting data about morbidity, disabil-
ity, and mortality; the other furnishes data about the 
prevalence of risk factors and their dynamics in re-
lation to preventive measures. Only few cohort and 
population-based epidemiological studies have been 
carried out in Latvia during the last 20 years.
These population-based and cohort epidemio-
logical studies mainly covered separate regions of 
Latvia (Riga, Kuldiga, etc.), patients with a cer-
tain diagnosis (diabetes mellitus, hypertension), or 
scheduled outpatient visits to family doctors’ prac-
tice (2–5). Moreover, to date, countrywide popu-
lation studies have not been performed on regular 
basis in Latvia. The rationale for the evaluation of 
cardiovascular disease (CVD) risk in the Latvian 
population was based on the following: 1) the evi-
dence that CVD is a major cause of morbidity and 
mortality, and it contributes to the increasing health 
care costs in Latvia; 2) CVDs are associated with 
modifiable lifestyle factors; and 3) the modification 
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of the population risk factor profile has been shown 
as a substantial tool to improve the data on CVD 
morbidity and mortality (6).
The above-mentioned facts in Latvia encour-
aged the creation of a new epidemiological database 
comprising the entire Latvian population. The first 
national cross-sectional population survey on car-
diovascular risk factors in Latvia was carried out in 
order to provide reliable information on the cardio-
vascular risk factor profile in an adult population. 
The survey was performed according to the inter-
nationally established standards and protocols (7, 8).
Material and Methods
This cross-sectional population-based survey was 
conducted from December 2008 to June 2009. The 
target population was all adults aged 25–74 years 
living in Latvia. The survey design and methodol-
ogy was approved by the Ethics Committee of Re-
search, Institute of Cardiology, University of Latvia. 
The Registry of Latvian Population served as a 
basis for selecting the representatives for this cross-
sectional study. Computerized simple random sam-
pling was done, where each person had equal chances 
to be selected. A total number of selected persons in 
this study were 6000. They were divided into 10 sub-
groups by 5-year age intervals. There were 600 par-
ticipants (300 men and 300 women) in each subgroup.
Recruitment of the subjects was performed by 
mobile study groups, which were temporarily locat-
ed in local outpatient clinics of the selected urban 
areas for a number of days. The subjects from a defi-
nite area were informed about the study place and 
time in advance by mail and/or telephone, and they 
were invited to visit the study group.
Of the 6000 persons invited to the study, 4198 
persons responded (communicated with us about 
their agreement to take part in the study), and 4022 
subjects came to the visit. A total of 176 persons 
were interviewed, but blood samples were not ob-
tained; 39 persons refused to be interviewed. A 
complete study sample included 3807 respondents 
(63.5% of the overall study population). 
The distribution of respondents by age and gen-
der is seen in Table 1, and the distribution by soci-
odemographic characteristics is presented in Table 2.
The study procedures were carried out by health 
care professionals fully trained to perform the in-
terview and examination. The training of the study 
staff was performed by specialists of the Research 
Institute of Cardiology, University of Latvia.  Each 
study group had 2 training seminars. Overall, there 
were 3 mobile study groups consisting of 2 phy-
sicians/interviewers, a nurse, and an assistant/data 
manager (12 people totally). A standardized inter-
view was carried out, together with the collection 
of anthropometric and biochemical data. The sur-
vey methodology was performed in accordance with 
the recommendations of the European Health Risk 
Monitoring Project (7).
The survey included an interview, based on a 
structured questionnaire, and physical examination. 
The survey questionnaire was based on the 
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Table 1. Distribution of Participants by Age and Gender
Men Women Gender Differences













































































*P<0.05 comparing men and women.
Table 2. Sociodemographic Characteristics of Study Population
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questions on socioeconomic status, symptoms, dis-
eases, and health behavior (8). Additional questions 
on risk factors, diseases, and treatment were in-
cluded from the EHRM protocol as well as from the 
WHO MONICA questionnaire. Smoking status was 
assessed using a standard set of questions follow-
ing the European Health Risk Monitoring project 
protocol. The questionnaire was pretested during 
October-November 2008. 
The questionnaire was completed, and height, 
weight, and blood pressure (BP) of the participants 
was recorded at the study place in the outpatient 
clinics. The examination was free of charge and last-
ed for an average of 35–40 minutes.
Weight was measured by a digital scale and 
height by a stadiometer, which was attached to a 
wall. Height and weight were used to calculate body 
mass index (BMI) in kg/m2. 
BP was measured by an automated validated de-
vice (OMRON M6 Comfort) (9) with the subject 
in a sitting position, on the subject’s right arm after 
having a rest for at least 5 minutes. 
Three measurements were taken with an inter-
val of 2–3 minutes. The last 2 measurements were 
averaged for the analysis. Venous blood samples 
were collected for fasting glucose (Glu), total cho-
lesterol (TC), triglycerides (TG), and high-density 
lipoprotein cholesterol (HDL-C) measurements in 
the morning after an overnight fasting period. The 
analysis of these samples was done in the certifi-
cated laboratories of one laboratory chain (10).
Another venous blood sample was taken and 
stored for future genetic analysis.
The following CVD risk factors were analyzed: 
1) arterial hypertension, if systolic blood pressure was 
more than 140 mm Hg and/or diastolic blood pres-
sure was more than 90 mm Hg or patients received 
antihypertensive treatment during the last 2 weeks; 
2) the BMI cutoff points of 25 and 30 kg/m2 were 
used to determine the overweight and obese subjects; 
3) smoking status based on the responses; the partici-
pants were classified into 3 categories: daily smokers, 
ex-smokers, and never smokers. The cutoff points of 
dyslipidemias and hyperglycemia were as follows: TC, 
≥5.0 mmol/L; TG, ≥1.70 mmol/L; low-density li-
poprotein cholesterol (LDL-C), >3.0 mmol/L; HDL-
C, ≤1.0 mmol/L for men and ≤1.2 mmol/L women, 
and Glu, ≥5.6 mmol/L. 
Data were analyzed using the SPSS for Win-
dows, version 12.0.
The input of measurements in the database was 
performed by 2 specialists independently.
Differences in the mean values of CVD risk fac-
tors between men and women in total and each age 
groups were assessed using the Mann-Whitney test 
(Z). Differences in the prevalence of CVD risk fac-
tors between age groups and gender were estimated 
by the chi-square test (χ2) for categorical variables 
(AH, BMI, smoking, and biochemical parameters). 
The associations between AH and age, number of 
risk factors and age, and between gender groups 
were evaluated by the Spearman rank correlation 
(rs). A P value of <0.05 was accepted as statistically 
significant.
Two different coding systems were used. One 
coding system was used for phenotypic informa-
tion; the other, for genotypic information. The phe-
notypic database was developed and stored in the 
Institute of Cardiology, University of Latvia. The 
genotypic database was created and stored in the 
Biomedical Study and Research Centre of Latvia. 
The Steering Committee (3 persons) and the 
Scientific Board (7 persons) were set up to super-
vise the study. 
Results
Cardiovascular Disease Risk Factors. The mean 
number of cardiovascular risk factors was 2.99±0.026 
per person for the overall study population. The 
male group had a significantly greater mean num-
ber of risk factors than the female group (3.45±0.04 
vs. 2.72±0.03, Z=13.557, P<0.001). Fig. shows that 
the number of risk factors increases with age both in 
men and women. A positive correlation between age 
(25–74 years) and number of risk factors was found 
(rs=0.096, P<0.001, in men; and rs=0.353, P<0.001 
in women). In the age group of 65 years and more, 
the mean number of risk factors decreased in men 
and stabilized in women. When the oldest age 
group (65–74 years) was excluded from the analy-
sis, a positive correlation between age and number 
of risk factors for men became stronger (rs=0.207, 
P<0.001), but it did not change essentially for wom-
en (rs=0.384, P<0.001). 
Fig. The mean number of risk factors per person 
by different age groups
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Blood Pressure. The prevalence of hypertension 
in the general study population was 44.8%. The 
percentage of men with hypertension was signifi-
cantly greater than that of women (52.9% vs. 40.2%, 
P<0.001) (Table 3).
The proportion of subjects with hypertension 
increased considerably with age in both genders 
(Table 4). This was confirmed by a positive correla-
tion between both variables among men (rs=0.27, 
P<0.001) and women (rs=0.40, P<0.001). 
Body Mass Index. The prevalence of overweight 
and obesity among the respondents was 37.7% and 
30.1%, respectively. Significant gender differences 
were revealed (P<0.001): overweight was docu-
mented in 44.6% of men and 33.7% of women; 
obesity, in 25.6% of men and 32.6% of women (Ta-
ble 3). Overweight as well as obesity increased with 
age among women and men (P<0.001) (Table 4).
Smoking. Less than one-third (30.5%) of men and 
11.4% of women reported to be daily smokers (Ta-
ble 3). The prevalence of daily smoking decreased 
with age in both the groups, but it was lower among 
women in all age groups (Table 4). There were more 
ex-smokers among older men aged 55–74 years as 
compared with younger men. The percentage of 
men who were ex-smokers slightly increased with 
age (P<0.008), while the percentage of daily smok-
ers significantly decreased (P<0.001). 
The percentage of women who had never smoked 
was greater in older than younger age groups.
Lipids and Glucose. The data about the preva-
lence of dyslipidemia and hyperglyceridemia are 
presented in Tables 3 and 5. The prevalence of in-
creased TC level was very high in both genders: 
72.0% and 78.0% in men and women, respectively, 
with a significant intergroup difference (P<0.003). 
Moreover, the prevalence of increased LDL-C level 
was very high in both gender groups: 73.1% and 
73.9% in men and women, respectively, but with-
out a significant group difference. The prevalence 
of decreased HDL-C level was 16.3% in the over-
all study population with a statistically significant 
difference between gender groups (P<0.01). More 
than one-third (27%) of the overall study popula-
tion had hypertriglyceridemia, and it was more 
prevalent among men than women (33.9% vs. 
24.1%, P<0.001). Hyperglycemia was documented 
in 39.2% of the investigated persons with a statisti-
cally significant difference between gender groups 
(P<0.001) (Table 3). With an exception for HDL-C, 
Risk Factor
All Population Men Women
















































































*P<0.05 comparing men and women. 
TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein 
cholesterol.
Table 3. Prevalence of Risk Factors in the Study Population
Category
25–34 years 35–44 years 45–54 years 55–64 years 65–74 years 
% % % % %
Men Women Men Women Men Women Men Women Men Women















































*P<0.05 comparing men and women.
Table 4. Prevalence of Arterial Hypertension, Overweight, Obesity and Smoking Habit in Men and Women 
in Different Age Groups
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the prevalence of all parameters showed a trend to 
increase with age in both gender groups (Table 5). 
However, it should be mentioned that in the age 
group of 65–74 years, the prevalence of dyslipidem-
ia was lower in comparison with the age group of 
55–64 years, especially in men. 
Discussion 
Some limitations should be acknowledged in 
this cross-sectional study. Particularly, the BP meas-
urements were taken twice after a rest of at least 5 
minutes but on the same occasion. It does not cor-
respond to the hypertension diagnostic algorithm 
requiring 2 BP measurements on separate occasions 
(11). This fact may cause the overestimated preva-
lence of hypertension. 
The level of nonresponse is a common problem, 
and this study was not an exception. A pretty high 
difference in the response rate was found between 
men and women as well as among some age sub-
groups. The level of responsiveness in both genders 
in the age group of 25–34 years did not reach the 
optimum; therefore, the results of this comparative 
analysis should be considered slightly limiting. The 
socioeconomic structure of the sample, compared 
to the background population from the 2009 census 
data, showed a little difference concerning the mari-
tal status and a slight underrepresentation of white-
collar workers in the male group. 
The strengths of this study include the large 
representative sample of general population from 
all regions of Latvia, the collection of data on vari-
ous lifestyle and CVD risk factors, medical data and 
measurements by trained staff according to the in-
ternationally accepted protocols allowing compari-
sons among countries (12–14).
The obtained results confirmed the study hy-
pothesis of high prevalence of cardiovascular risk 
factors in the Latvian population. Moreover, no 
significant improvements have been observed when 
compared with the previous epidemiological or 
health behavior studies (2–4, 15), especially for ar-
terial blood pressure and body mass index. 
A high number of risk factors in young male 
population are an unfavorable finding (>2.5 risk fac-
tors in men aged 25 to 34 years) showing the direc-
tion for preventive measures to be taken.
A decrease in the number of risk factors in men 
aged more than 64 years requires further analysis. 
A desirable explanation could be, for example, a 
decrease in the smoking prevalence. Nonetheless, 
the fact that the average life expectancy in Latvia 
in 2010 for men and women was 67.3 and 77.8 
years, respectively, cannot be ignored (1). There-
fore, a number of men at high cardiovascular risk 
do not survive over the age of 64 years. Obviously, 
the number and distribution of risk factors in men 
aged more than 64 years could undergo substantial 
changes. As a reason for the abovementioned could 
be the change of a positive correlation between age 
and number of risk factors if the older age/gender 
group (65–74 years) was excluded from the analysis. 
The correlation became stronger in the male group, 
while did not change essentially in women.
Overall, 44.8% of all the participants were rec-
ognized as hypertensive. The prevalence of hyper-
tension seems to be close to the data from cross-
sectional surveys conducted in several European 
countries (the United Kingdom, Spain, Italy, Hun-
gary, Poland, and Germany) (12, 14). The results 
of the investigations revealed that in the same age 
group as in our study, the prevalence of hyperten-
sion was 60.1% in men and 38.5% in women in Ger-
many (4000 people, 2001); in the UK national sam-
ples (1998 and 2003), 41.5% of men and 33.3% of 
women had AH, and in Poland, 44.0% and 35.0%, 
respectively. Both the primary prevention and the 
good management of hypertension will be future 
challenges in Latvia as the prevalence of some of the 
contributing factors, such as overweight and obe-
sity, is likely to increase (2–4).
The high prevalence of obesity demonstrated in 
this study as well as the accumulation of other CVD 
risk factors in the middle-aged groups are likely to 
increase the burden of CVD and diabetes in the im-
mediate future. The prevalence of hyperglycemia 
Category
25–34 yrs 35–44 yrs 45–54 yrs 55–64 yrs 65–74 yrs
% % % % %



































































*P<0.05 comparing men and women.
TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein 
cholesterol.
Table 5. Prevalence of Dyslipidemia and Hyperglycemia in Men and Women in Different Age Groups
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(blood glucose level, ≥7.0 mmol/L) was approxi-
mately 5% and 6% in women and men, respectively. 
These data highlight the problem of diabetes mel-
litus in Latvia, although an increasing trend has al-
ready been expected (16).
The attention should be paid to the dyslipidemia 
profile found in this study: a very high prevalence 
of increased TC and LDL-C levels, increasing with 
age, a lower prevalence of abnormal TG level, which 
is stable in men with increasing age, and a low prev-
alence of decreased HDL-C. Of interest is the find-
ing about the improvement of lipid profile in the 
age group of 65–74 years especially in men, if com-
pared to younger age groups. We have no sufficient 
information about better medication strategy or 
better compliance in this age group that could ex-
plain this improvement of lipid profile. In addition, 
on the other hand, some other explanation could 
be the death of people with a very high level of risk 
factors in the middle-aged group, especially, among 
men. To note, the male life expectancy at birth in 
Latvia in 2009 was 68.3 years.
It is worth to note that the high prevalence of 
decreased HDL-C level and increased TG level has 
never been a problem in Latvia as it is shown in the 
previous epidemiological studies (3–4). 
To note, the European Action on Secondary 
and Primary Prevention by Intervention to Reduce 
Events III (EUROASPIRE III) survey on the man-
agement of CVD prevention in Europe has reported 
the high prevalence of increased TC and LDL-C 
levels in Latvia: 64.0% of the coronary patients had a 
TC level of ≥4.5 mmol/L and 62.8% of patients had 
a LDL-C level of ≥2.5 mmol/L (17). These data re-
veal a problem at the level of secondary prevention. 
In Latvia, 73%–80% of the patients with coronary 
heart disease use lipid-lowering drugs in the frame-
work of secondary prevention (17); thus, the lower 
prevalence of dyslipidemia was expected to be found 
in this patients’ group in comparison with other Eu-
ropean countries. Whatever the case could be, the 
reasons of the above-described dyslipidemia profile 
have to be investigated in future studies.
An ever-increasing number of epidemiological 
studies have identified smoking as one of the most 
important risk factors for noncommunicable diseas-
es, including CVDs. The prevalence of smoking in 
Latvia is still rather high; however, the mean smok-
ing prevalence has decreased in men in comparison 
with our previous cross-sectional population studies 
and the FINBALT health behavior study (2–4, 15). 
To note, it could be admitted that the lower preva-
lence of daily smoking among men in the current 
study might be caused by an insufficient represen-
tation of younger age groups. However, the com-
parison of smoking prevalence in our study with the 
data of the abovementioned studies (2–4, 15) clearly 
demonstrated the decreased prevalence of smoking 
among men in all compared groups of equal age.
The finding that smoking is most prevalent in 
a younger age group, especially among women, 
might reflect the contemporary smoking habit in 
adolescence in general. This alarming fact was also 
confirmed by the study on smoking habits among 
teenagers performed within the framework of the 
WHO-supported International study “Health Be-
haviour in School-Aged Children” (18). It has been 
shown that in Latvia, 23.5% of 15-year-old adoles-
cent boys and 15.4% of girls are daily smokers. 
Comparing the risk factor profile in Latvia with 
the countries that have already dealt with the prob-
lem of CVD mortality, we can find some didactic 
correlations. The analysis of CVD risk factors with-
in the 35-year period in Finland (6) has shown a tre-
mendous improvement in the lipid profile: the prev-
alence of normal TC level (≤5.0 mmol/L) in 1972 
was 6% for men and 7% for women, but in 2007, it 
increased to 36% and 46%, respectively. The dynam-
ics of elevated BP and smoking is similar: the preva-
lence of elevated systolic BP declined from 64% in 
men and from 65% in women to 46% and 38%, re-
spectively. The smoking prevalence decreased from 
52% to 31% among men, but it increased from 10% 
to 18% among women. Therefore, we can say that 
the risk factor profile in Finland in 2007 was close to 
our findings in Latvia in 2009. The CVD mortality 
rate in Finland during the 35-year period declined 
to a range between 370 per 100 000 and 390 per 
100 000 in men and women, respectively, which was 
explained by the decline of combined risk by 60% 
during these years (6). However, in Latvia, the CVD 
mortality rates during the last 5 years were found 
to be 2 times higher: 750–760 per 100 000 popula-
tion in men and 780–790 per 100 000 population in 
women. From these comparisons of CVD risk fac-
tors and mortality rates, we can speculate that be-
sides the impact of risk factors on mortality rates, 
there is a wider spectrum of other factors influenc-
ing CVD mortality in Latvia comparing to Finland 
including differences in a socioeconomic situation, 
access to medical services, etc.
Future longitudinal population-based studies 
should focus on more precise characterization of the 
data obtained in order to estimate the interaction of 
different risk factors and assess the contribution of 
each of them in the course of illness. This could help 
the option of adequate and effective intervention.
Conclusions
This first population-based cross-sectional epi-
demiological study of cardiovascular risk factors in 
Latvia covering the entire country has established a 
high prevalence of classical cardiovascular risk fac-
tors. The data can be utilized as baseline charac-
A Study of Cardiovascular Risk Factors in Latvia
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teristics against which other measurements can be 
compared down the road including the monitoring 
of health prevention activities.
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